Previous 10 | Next 10 |
Summary My projected dividend growth is up 9.9904% over 2021, and I'll likely surpass my 10% hurdle rate this month. I pooled my monthly dividends and reinvested in two of my favorite high-quality companies. I used my monthly savings to add to three of my favorite companies. ...
Summary Fisher’s 13F portfolio value decreased from ~$141B to ~$133B in Q3 2022. They added Charles Schwab and increased Nvidia, Morgan Stanley, and Goldman Sachs while decreasing Salesforce, Visa, Alibaba Group Holdings, Novartis, Verizon, and Tencent Holdings. The top...
Summary Investors today are desperate for income to help overcome the ravages of inflation. ETY generates income by investing in a portfolio of stocks and then writing indexed call options. The fund is very concentrated in a few technology stocks that have underperformed the S...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Last week, real estate firm Zumper reported that rents in Boston had jumped 20% year over year. The median cost for a one-bedroom apartment now sits at $3,060 — a figure that would consume 45% of a median worker...
Summary The Akre Focus Fund invests in a small number of what we believe to be extraordinary businesses that are run by talented and honest managers who wisely reinvest free cash flow. It is likely that 2022 will be the first negative performance year in the fund’s 13-year ...
Summary Healthcare industry, especially the large-cap pharmaceutical, biotechnology, and managed healthcare stocks are doing well and outperforming the market. More stocks in THQ’s top 70 percent equity portfolio generated high positive price growth than the number of stock...
No one said investing was easy. And you will struggle to find anyone who says that the recent results of life sciences and diagnostics company Danaher (NYSE: DHR) were easy to understand. The company's earnings and revenue are moving around a lot due to the impact of COVID-19-relate...
Summary FIW holds 36 companies that derive a substantial portion of their revenues from the potable and wastewater industry. The fund's popularity is increasing, now with $1.14 billion in AUM. However, even considering the sharp decline this year, FIW trades at an expensive 26.77x...
Summary Since I warned investors last year about Danaher's high valuation, the stock price has fallen more than -20%. In this article, now that Danaher's price has come down, I analyze the stock again. This time, an even bigger risk is present for DHR stock. Introduc...
Summary Danaher just reported its third-quarter earnings, which showed strong organic growth and pricing power despite economic challenges. The company is witnessing easing supply chain issues and confirmed its full-year outlook. Shares are down 25% year-to-date, which is a re...
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 10:45:04 ET Pacific Biosciences of California Inc (PACB) PACB is trading UP for the last 5 days, and it at trading at $2.10 with volume of 3,952,245 and a one day change of $0.19 (9.97%). Pacific Biosciences of California Inc has a 52-week low of 1.16 and a 52-week high o...
Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration PR Newswire BREA, Calif. , July 25, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the Dx...
2024-07-23 20:30:03 ET Goldman Sachs analyst issues NEUTRAL recommendation for DHR on July 23, 2024 06:19PM ET. The previous analyst recommendation was Neutral. DHR was trading at $264.18 at issue of the analyst recommendation. The overall analyst consensus : BUY. Cu...